• 1
    Kang YG, Martin DJ, Marquez J, Lewis JH, Bontempo FA, Shaw BW Jr, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985; 64: 888896.
  • 2
    Kang Y. Coagulation and liver transplantation: current concepts. Liver Transpl Surg 1997; 3: 465467.
  • 3
    Nielsen V. The detection of changes in heparin activity in the rabbit: a comparison of anti Xa activity, thromboelastography, activated partial thromboplastin time and activated coagulation time. Anesth Analg 2002; 95: 15031506.
  • 4
    Coppell J, Thalheimer U, Zambruni A, Triantos C, Riddell A, Burroughs A, Perry D. The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the TEG: an in vitro comparison of standard and heparinase modified TEGs with conventional coagulation assays. Blood Coagul Fibrinolysis 2006; 17: 97104.
  • 5
    Senzolo M, Coppell J, Cholangitas E, Burroughs A. The effects of glycosaminoglycans on coagulation: a thromboelastographic study. Blood Coagul Fibrinolysis 2007; 18: 227236.
  • 6
    Harding SA, Mallett SV, Peachey TD, Cox DJ. Use of heparinase modified thromboelastography in liver transplantation. Br J Anaesth 1997; 78: 175179.
  • 7
    Bakker C, Stibbe J, Gomes M, Groenland T, Metselaar H, Hesselink E, et al. The appearance of donor heparin in the recipient after reperfusion of a liver graft. Transplantation 1993; 56: 327329.
  • 8
    Kettner S, Gonano C, Seebach F. Endogenous heparin-like substances significantly impair coagulation in patients undergoing orthotopic liver transplantation. Anesth Analg 1998; 86: 691695.
  • 9
    McKee R, Hodson S, Dawes J, Garden O, Carter D. Plasma concentrations of endogenous heparinoids in portal hypertension. Gut 1992; 33: 15491552.
  • 10
    Jakab F, Zavodszky Z, Sugar I, Ughy T. Changes in heparin level in experimental liver transplantation in dog. Acta Chir Hung 1988; 29: 1520.
  • 11
    Nielsen V, Geary B. Hepatoenteric ischaemia-reperfusion increases circulating heparinoid activity in rabbits. J Crit Care 2000; 15: 142146.
  • 12
    Zambruni A, Thalheimer U, Coppell J, Riddell A, Mancuso A, Leandro G, et al. Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and non-cirrhotic patients. Scand J Gastroenterol 2004; 39: 830836.
  • 13
    Ben-Ari Z, Panagou M, Patch D, Bates S, Osman E, Pasi J, Burroughs A. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by TEG. J Hepatol 1997; 26: 554559.
  • 14
    Segal H, Cottam S, Potter D, Hunt B. Coagulation and fibrinolysis in PBC compared with other liver disease and during OLT. Hepatology 1997; 25: 683688.
  • 15
    Bayly R, Thick M. Reversal of post reperfusion coagulopathy by protamine sulphate in orthotopic liver transplantation. Br J Anaesth 1994; 73: 840842.
  • 16
    Steib A, Freys G, Lehmann C, Meyer C, Mahoudeau G. Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Can J Anaesth 2001; 48: 10751079.
  • 17
    Hendriks HG, van der MJ, Klompmaker IJ, Choudhury N, Hagenaars JA, Porte RJ, et al. Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients. Blood Coagul Fibrinolysis 2000; 11( suppl 1): S87S93.
  • 18
    Pivalizza E, Abramson D, King F. Thromboelastography with heparinase in orthotopic liver transplantation. J Cardiothor Vasc Anesth 1998; 12: 305825.
  • 19
    Rivard G, Brummel-Ziedins K, Mann K, Fan L, Hofer A, Cohen E. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thromboelastography. J Thromb Haem 2005; 3: 20392043.
  • 20
    Chau TN, Chan YW, Patch D, Tokunaga S, Greenslade L, Burroughs AK. Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding. Gut 1998; 43: 267271.
  • 21
    Verstraete M. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins. Drugs 1990; 40: 498530.
  • 22
    Bjornsson TD, Wolfram K. Intersubject intervariability in the anticoagulant response to heparin in vitro. Eur J Clin Pharmacol 1982; 21: 491497.
  • 23
    Monteagudo J, Reverter JC, Pereira A, Pijoan J, Balust J, Escolar G, et al. Prothrombin fragment 1 + 2 and thrombin-antithrombin complex measurements indicate continuous and progressive intraoperative thrombin generation in liver transplantation. Haemostasis 1993; 23: 5157.
  • 24
    Bouma B, Mosnier L. Thrombin activatable fibrinolysis inhibitor—TAFI—how does thrombin regulate fibrinolysis? Ann Med 2006; 38: 378388.